Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?

被引：0
|
作者：
Hamedi, Z. [1 ]
Kamboj, S. [2 ]
Kumar, S. [1 ]
Jiwani, R. A. [1 ]
Sharma, N. [2 ]
机构：
[1] East Carolina Univ, Vidant Med Ctr, Internal Med, Greenville, NC 27858 USA
[2] East Carolina Univ, Vidant Med Ctr, Hematol & Oncol, Greenville, NC 27858 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
    Bar, Jair
    Ofek, Efrat
    Barshack, Iris
    Gottfried, Teodor
    Zadok, Oranit
    Kamer, Iris
    Urban, Damien
    Perelman, Marina
    Onn, Amir
    LUNG CANCER, 2019, 138 : 109 - 115
  • [2] Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
    Eckardt, J. R.
    Ramlau, R.
    Gervais, R.
    Shepherd, F.
    O'Brien, M.
    Ciuleanu, T.
    Dharan, B.
    Wissel, P.
    Ross, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 387S - 387S
  • [3] Small cell transformation as a mechanism of resistance to immunotherapy of non-small cell lung cancer
    Bar, Jair
    Urban, Damien
    Kuznetsov, Teodor
    Gadot, Moran
    Zadok, Oranit
    Kamer, Iris
    Perelman, Marina
    Onn, Amir
    Ofek, Efrat
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [5] CHEMOTHERAPY FOR CEREBRAL METASTASES IN SMALL CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC)
    TWELVES, C
    SOUHAMI, R
    HARPER, P
    TOBIAS, J
    SPIRO, S
    GEDDES, D
    ASH, C
    DRAKE, J
    THORAX, 1988, 43 (10) : P841 - P841
  • [6] Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
    Rath, Barbara
    Plangger, Adelina
    Hamilton, Gerhard
    CANCER DRUG RESISTANCE, 2020, 3 (02) : 171 - 178
  • [7] Should we use small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC)-based therapy for the treatment of large cell neuroendocrine cancer (LCNEC) of the lung?
    Karim, Nagla Fawzy Abdel
    Namad, Tariq
    Ying, Jung
    Wang, Jiang
    Bhatt, Ananta
    Sakkal, Mohamed
    Morris, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] CEREBRAL METASTASES IN SMALL CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC) TREATED BY CHEMOTHERAPY
    TWELVES, C
    SOUHAMI, R
    HARPER, P
    TOBIAS, J
    SPIRO, S
    GEDDES, D
    ASH, C
    DRAKE, J
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 461 - 461
  • [9] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [10] The cost of non-small cell lung cancer (NSCLC) treatment
    Vergnenegre, A.
    ONCOLOGIE, 2012, 14 (05) : 310 - 315
12345